CAR-T cell therapy has one of the most academically rooted and legally tested patent landscapes in biotechnology. A chimeric antigen receptor T-cell is engineered by giving a patient's T-cells a synthetic receptor that directs them against a cancer target, and the intellectual property spans several distinct layers: the CAR construct itself, with its antigen-binding domain, hinge, transmembrane region, costimulatory domain, and signaling domain; the viral vectors used to introduce it; the manufacturing and cell-processing methods; and the methods of use for specific indications. Because these layers are patented separately and often by different owners, freedom-to-operate for a CAR-T product is a multi-layer, multi-owner analysis rather than a single clearance.

The foundational patents emerged from academic laboratories and were then in-licensed or acquired by commercial developers, which shaped the ownership structure. Peer-reviewed analyses of CAR-T patenting activity trace the field's key early filings to academic groups, with foundational work associated with Carl June at the University of Pennsylvania and Michel Sadelain at Memorial Sloan Kettering Cancer Center, before commercialization by large pharmaceutical companies.¹,² This academic origin is visible in the ownership record: across the Cypris corpus of more than 500 million patents and scientific papers, the most active assignees in the CAR-T set are led by the University of Pennsylvania, followed by the US Department of Health and Human Services and the National Institutes of Health, the University of California San Diego, the University of Texas System, and Memorial Sloan Kettering, interleaved with commercial developers such as Novartis, Juno Therapeutics, and Kite Pharma. Peer-reviewed patent-landscape analyses describe a field of fierce competition and intensive academic-industry collaboration,¹ with one review mapping more than 1,600 patent families across the field's technological routes,³ and product-patent-linkage studies have detailed how the portfolios behind approved CAR-T products are assembled from the construct, vector, manufacturing, and method-of-use layers.⁴ Analyses of academic CAR-T patenting also document the pitfalls that arise when university filings are drafted for disclosure rather than durable claim scope.⁵ A recurring finding is that many foundational filings date to the late 1990s and early 2000s, so their earliest members are now reaching the end of their patent terms, which shifts value toward improvement patents on next-generation constructs, allogeneic and off-the-shelf approaches, and manufacturing.¹,³ Across the Cypris corpus, CAR-T patent families grew from about 2,882 in 2018 to about 9,118 in 2024, with 2025 counts partial because of the roughly eighteen-month publication lag.

Litigation defined the landscape's risk profile. In the dispute between Juno Therapeutics, which exclusively licensed a foundational receptor patent from Memorial Sloan Kettering, and Kite Pharma over its approved therapy, a jury initially found for Juno, but on August 26, 2021 the US Court of Appeals for the Federal Circuit reversed and held the foundational patent's asserted claims invalid for lack of adequate written description, reasoning that disclosing a small number of specific binding domains did not show possession of the far broader claimed genus.⁶ A peer-reviewed analysis in Biotechnology Law Report situated the decision as a strike against broadly drafted, pioneering biotechnology claims.⁷ The decision reshaped the field, because it raised questions about the validity of broadly drafted foundational biotech patents generally, and it signaled that in cell therapy the durable value may lie in specific, well-supported improvement claims rather than pioneering-but-broad foundational ones. Because applications publish about eighteen months after filing, the most recent activity in next-generation and allogeneic approaches is under-represented, so the current frontier is more active than granted-patent counts suggest.

What creates FTO risk in CAR-T products

CAR construct claims. These cover the receptor's components, including antigen-binding domain, costimulatory domain, and signaling domain, the core of many disputes.

Viral vector claims. These cover the vectors used to introduce the receptor, a distinct and separately owned layer.

Manufacturing and cell-processing claims. These cover how the therapy is produced, which is increasingly where competitive differentiation and IP concentrate.

Method-of-use claims. These cover use for specific indications and patient populations, so a construct can be free for one use and blocked for another.

Next-generation and allogeneic claims. These cover off-the-shelf, gene-edited, and next-generation approaches, a fast-growing layer where new FTO risk and white space are emerging.

How AI-powered landscape and FTO analysis helps

A multi-layer, academically rooted, litigated landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant construct, vector, manufacturing, and use claims regardless of terminology, attribution that resolves academic and commercial owners to canonical entities and captures the license and acquisition chains, and continuous monitoring that tracks next-generation filings and litigation developments. Because cell-therapy advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for multi-layer, academically rooted fields such as CAR-T across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by layer, construct, vector, manufacturing, and use, and normalizes academic and commercial owners to canonical entities, so a team can trace how rights and licenses are distributed rather than read a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying research, which is where next-generation and allogeneic approaches emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is the CAR-T patent landscape distinctive? The CAR-T patent landscape is distinctive because it is deeply rooted in academic research and has been heavily litigated. Foundational patents came from university labs and were licensed or acquired by commercial developers, and the IP spans the receptor construct, viral vectors, manufacturing, and methods of use. Freedom-to-operate is therefore a multi-layer, multi-owner analysis.

What claim types create FTO risk in CAR-T? Five claim types create FTO risk in CAR-T: CAR construct claims, viral vector claims, manufacturing and cell-processing claims, method-of-use claims, and next-generation or allogeneic claims. Each is independently patentable and can be held by a different owner. Construct and manufacturing layers are especially contested.

What was the Juno v. Kite decision? In Juno v. Kite, Juno Therapeutics asserted a foundational CAR receptor patent it had licensed from Memorial Sloan Kettering against Kite Pharma's approved therapy. A jury initially found for Juno, but the US Court of Appeals for the Federal Circuit in 2021 reversed and struck down the foundational patent for lack of adequate written description. The decision reshaped the field and raised questions about broadly drafted foundational biotech patents.

Why are CAR-T foundational patents reaching the end of their terms important? Many CAR-T foundational filings date to the late 1990s and early 2000s, so their earliest members are now reaching the end of their patent terms, which shifts value away from the original broad claims toward improvement patents. These cover next-generation constructs, allogeneic and off-the-shelf approaches, and manufacturing. FTO analysis must therefore focus increasingly on the improvement layer.

Where did CAR-T foundational patents come from? CAR-T foundational patents came largely from academic laboratories, with key work associated with Carl June at the University of Pennsylvania and Michel Sadelain at Memorial Sloan Kettering Cancer Center. These filings were in-licensed or acquired by commercial developers who brought products to market. This academic origin shaped the landscape's ownership and licensing structure, which is visible in the assignee record.

Why does CAR-T analysis need scientific literature? CAR-T analysis needs scientific literature because construct, manufacturing, and next-generation advances appear in research before they are patented, so the literature gives the earliest signal of where the field is heading. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

Which teams need CAR-T patent landscape and FTO analysis? CAR-T patent landscape and FTO analysis is needed by R&D, IP, and business-development teams at cell-therapy and pharmaceutical companies, academic technology-transfer offices, and investors assessing cell-therapy assets. The multi-layer, litigated landscape makes structured analysis essential. Cypris serves hundreds of enterprise customers across pharmaceuticals and other research-intensive industries.

How current does a CAR-T landscape need to be? A CAR-T landscape needs to be continuously current, because foundational patents are reaching the end of their terms, next-generation and allogeneic filings publish constantly, and publication lag hides the most recent activity. A one-time landscape ages quickly. Cypris uses Agentic Monitoring to track the landscape and flag new filings and developments as they publish.

‍
Endnotes

1. Lyu, L., Chen, X., Hu, Y., & Feng, Y. (2020). The global chimeric antigen receptor T (CAR-T) cell therapy patent landscape. Nature Biotechnology, 38(12). https://doi.org/10.1038/s41587-020-00749-8
2. Clarke, N. S., & Jürgens, B. (2019). Evolution of CAR T-cell immunotherapy in terms of patenting activity. Nature Biotechnology, 37(4). https://doi.org/10.1038/s41587-019-0083-5
3. Malmegrim, K. C. R., Picanço-Castro, V., Pereira, C. G., Covas, D. T., Porto, G. S., & Swiech, K. (2019). Emerging CAR T cell therapies: clinical landscape and patent technological routes. Human Vaccines & Immunotherapeutics, 16(6). https://doi.org/10.1080/21645515.2019.1689744
4. Kano, S., & Kawai, Y. (2025). Expanding the concept of drug lifecycle management to chimeric antigen receptor T-cell products through product-patent linkage analysis. World Patent Information, 81. https://doi.org/10.1016/j.wpi.2025.102357
5. Constantinescu, C., Gulei, D., Bergþorsson, J. Þ., Coliţă, A., Tănase, A., Tomuleasa, C., Greiff, V., & Constantinescu, R. (2023). Pitfalls in patenting academic CAR-T cells therapy. Expert Opinion on Therapeutic Patents, 33(6). https://doi.org/10.1080/13543776.2023.2220883
6. U.S. Court of Appeals for the Federal Circuit (Aug. 26, 2021). Juno Therapeutics, Inc. v. Kite Pharma, Inc., 10 F.4th 1330. https://www.cafc.uscourts.gov/opinions-orders/20-1758.opinion.8-26-2021_1825257.pdf
7. Holman, C. M. (2021). In Juno v. Kite the Federal Circuit strikes down patent directed towards pioneering innovation in CAR T-cell therapy. Biotechnology Law Report, 40(6). https://doi.org/10.1089/blr.2021.29252.cmh

‍

Fault-tolerant quantum computing has become the organizing goal of the entire quantum-hardware industry, and its patent landscape is distinctive because the central problem is not building more qubits but building qubits that stay correct while computing. Fault-tolerant quantum computing combines many noisy physical qubits into one error-protected logical qubit through a quantum error-correcting code, with the goal of "below-threshold" operation, where adding more physical qubits per logical qubit exponentially suppresses the logical error rate rather than accumulating it. Google's Quantum AI team demonstrated this directly on a superconducting processor: scaling a surface code from distance-3 to distance-5 to distance-7 suppressed the logical error rate by roughly a factor of two per code-distance increment, with the resulting logical qubit's lifetime exceeding that of its best constituent physical qubit — the first hardware-scale confirmation of below-threshold scaling¹. On neutral-atom hardware, a Harvard/MIT/QuEra collaboration demonstrated a logical quantum processor with up to 48 logical qubits and reconfigurable connectivity, performing transversal operations — a milestone that is substantially error-detected and algorithmic in character rather than a fully fault-tolerant computation with continuous real-time correction². Trapped-ion platforms have separately demonstrated real-time logical-qubit error detection and correction³. The intellectual property divides across several regions, each a distinct area of patenting: the qubit modality itself, including superconducting circuits, trapped ions, neutral atoms, photonic qubits, and bosonic (cat) qubits; the error-correcting code, including the mature surface code and the newer quantum low-density parity-check (qLDPC) codes, which promise a substantially better ratio of logical to physical qubits at the cost of the non-local connectivity they require — a constraint that recent work specifically targets with 2D-local implementations⁴,⁵; the real-time decoding hardware and software that must detect and correct errors fast enough to keep pace with computation, an area seeing progress in network-integrated decoding for lattice surgery at scale⁶; and the interconnect and networking technology needed to link separate processors, an approach with early metropolitan-scale demonstrations, including work toward entanglement swapping across roughly 30 kilometers in a three-node network in New York City⁷. Because a competitive fault-tolerant architecture depends on all of these layers working together, and because different companies are betting on different qubit modalities, freedom-to-operate and white space analysis must span modality and code together.

Bosonic, or "cat," qubits are a distinct and increasingly well-evidenced hardware-efficiency route: by engineering the qubit itself to exponentially suppress bit-flip errors as a function of mean photon number, cat-qubit architectures convert the correction problem into one of handling a biased, phase-flip-dominated error channel, with experimental bit-flip times pushed past ten seconds in one demonstration⁸. Multiple hardware vendors have published multi-year roadmaps that should be read as stated targets rather than achieved milestones: IBM's own roadmap targets a system called Starling for 2029, running 100 million gates on 200 logical qubits, while Quantinuum's own roadmap targets a universal, fully fault-tolerant system by the end of the decade⁹. Because applications publish about eighteen months after filing, the newest decoder, qLDPC-code, and interconnect filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer of the stack a given owner can actually defend, and the white space sits where engineering, not physics, is now the bottleneck. Qubit-modality IP is comparatively mature and fragmented across several well-funded, differently architected companies, so no single modality currently dominates the landscape. The faster-moving and more open ground is in error-correcting-code implementation — particularly qLDPC codes, which are newer and less thoroughly claimed than the surface code, and whose central practical obstacle (non-local connectivity) is itself an active area of new filings — real-time classical decoding hardware, which must operate fast enough not to become the new bottleneck once qubits themselves are reliable, and quantum networking, which several companies are pursuing as an alternative to scaling a single monolithic chip. Reading the landscape by modality, code, and layer, and tracking both the patents and the underlying quantum-information-science research, is what separates a defensible architectural bet from a crowded one.

Where the fault-tolerant quantum computing white space is

Quantum LDPC codes and their connectivity solutions. Codes promising a better logical-to-physical-qubit ratio than the surface code are newer and less thoroughly claimed, and the 2D-local implementations needed to make them practical are themselves an active, comparatively open filing area⁴,⁵.

Real-time decoding hardware and software. Classical decoders that detect and correct errors fast enough to keep pace with a scaling quantum processor are an increasingly critical, comparatively open layer⁶.

Bosonic and cat-qubit architectures. Hardware-efficient codes that build error protection into the physical qubit itself, reducing the number of physical qubits needed per logical qubit, remain a less-crowded alternative to surface-code-based approaches⁸.

Quantum networking and multi-node architectures. Linking separate quantum processors — including early metropolitan-scale demonstrations over standard fiber-optic infrastructure — is an emerging alternative to monolithic scaling, with comparatively little settled IP⁷.

Verified, primary-sourced roadmap claims. Because most public logical-qubit and gate-count targets are company roadmap statements rather than demonstrated results, an owner able to substantiate claims against peer-reviewed, independently reproducible results has a genuine differentiation and credibility advantage.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans five-plus qubit modalities, several competing error-correcting codes, and the classical and networking engineering needed to scale them requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by modality, code, and layer across varied and fast-evolving terminology, attribution that normalizes hardware-vendor, national-lab, and university filers to canonical entities, and continuous monitoring that keeps pace with a field where major technical milestones are being announced multiple times per year. Because quantum-information-science advances appear in physics literature and preprints before they are patented, reading both patents and literature gives the earliest signal of which code and modality combination is actually closing the gap to fault tolerance — and helps separate demonstrated results from roadmap targets.

The competitive landscape by the numbers

Cypris's corpus puts the quantum error correction / fault-tolerant quantum computing patent family set at roughly 11,928 documents, heavily concentrated in the United States (approximately 5,076 families), followed by China (approximately 1,655) and Canada (approximately 561) (Cypris corpus, indicative; 2025–26 partial). Filing activity has accelerated sharply, from roughly 578 new families in 2020 to about 2,328 in 2025, with 2026 partial at approximately 1,791 (Cypris corpus, indicative; 2025–26 partial). Top assignees are led by superconducting and gate-model incumbents alongside quantum-native firms — Google, IBM, Microsoft, D-Wave, and Rigetti — with Yale, IonQ, Harvard, and MIT also present in the assignee list (Cypris corpus, indicative; 2025–26 partial). A clean split of this corpus by qubit modality and by code/decoder/interconnect layer was not available from this pass; the assignee mix, however, skews toward superconducting and trapped-ion players, consistent with where the demonstrated hardware results described above are concentrated.

Where Cypris fits

Cypris runs patent landscape and white space analysis for fast-moving, deep-technical fields such as fault-tolerant quantum computing across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by qubit modality, superconducting, trapped-ion, neutral-atom, photonic, and bosonic, and by layer, error-correcting code, decoding hardware, and interconnect, and normalizes hardware-vendor, national-lab, and university filers to canonical entities, so a team can resolve which modalities and layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying quantum-information-science research, which is where fault-tolerance advances appear first, often well ahead of the patent record. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined modality or layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is fault-tolerant quantum computing? Fault-tolerant quantum computing encodes one error-protected "logical" qubit across many noisy physical qubits using a quantum error-correcting code, targeting "below-threshold" operation, where scaling the code exponentially suppresses the logical error rate. Google demonstrated this directly on superconducting hardware, showing logical error rate falling by roughly 2x per code-distance increment with a logical qubit outliving its best physical qubit¹. It is the prerequisite for running large, reliable quantum programs.

What qubit modalities does the landscape cover? The landscape covers superconducting circuits, trapped ions, neutral atoms, photonic qubits, and bosonic (cat) qubits, each with different native error rates, connectivity, and scaling challenges. No single modality currently dominates the field; Cypris's corpus shows assignees spanning superconducting incumbents (Google, IBM, D-Wave, Rigetti) and trapped-ion and academic players (IonQ, Yale, Harvard, MIT). Each modality is pursued by a differently architected set of developers.

What is a logical qubit, and how many have actually been demonstrated? A logical qubit is an error-protected unit of quantum information built by combining many physical qubits under an error-correcting code. As of the most recent peer-reviewed demonstrations, a neutral-atom platform has shown up to 48 logical qubits with reconfigurable connectivity in an error-detected, largely algorithmic demonstration², and superconducting hardware has demonstrated below-threshold scaling on a smaller logical-qubit count¹. These are well short of the hundreds to thousands of logical qubits that company roadmaps target for the end of the decade⁹.

What claim types create IP activity in fault-tolerant quantum computing? Four layers generate the bulk of IP activity: qubit-modality hardware, error-correcting-code implementation (including the connectivity solutions that make qLDPC codes practical), real-time decoding hardware and software, and interconnect and networking technology. Each is a distinct region of patenting, often held by different companies pursuing different architectural bets. A competitive fault-tolerant system depends on progress across all four.

Where is the white space in fault-tolerant quantum computing? The white space includes qLDPC codes and their connectivity solutions, real-time decoding hardware and software, bosonic/cat-qubit architectures, and quantum networking and multi-node architectures. Qubit-modality IP is comparatively mature and fragmented. The newer error-correcting codes and the classical and networking engineering around them are the most open, high-value ground.

How reliable are company roadmap claims in this field? Company roadmap claims should be read as stated targets, not demonstrated results — IBM's and Quantinuum's own published roadmaps target hundreds to thousands of logical qubits by the end of the decade⁹, well beyond what has been peer-reviewed and demonstrated to date¹,². Distinguishing "demonstrated" from "roadmap target" is essential to reading this field accurately. Analysts and IP teams should trace any specific qubit-count or timeline claim back to its primary source before relying on it.

Why does fault-tolerant quantum computing analysis need scientific literature? Fault-tolerant quantum computing analysis needs scientific literature because error-correcting-code and decoder advances appear in physics research and preprints before they are patented, so the literature gives the earliest signal in a field where major milestones are announced several times a year. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

Which teams use fault-tolerant quantum computing patent landscape analysis? Fault-tolerant quantum computing patent landscape analysis is used by R&D, IP, and strategy teams at quantum-hardware companies, national laboratories, and technology-company quantum divisions, as well as investors assessing the sector. Because the landscape spans multiple competing qubit modalities and codes at different maturity levels, structured analysis is essential to choosing where to build and where to partner. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.

Endnotes

1. Bausch J, Malone FD, Martin LS, et al. Quantum error correction below the surface code threshold. Nature. DOI: 10.1038/s41586-024-08449-y.
2. Geim AA, Bluvstein D, Gullans MJ, Kalinowski MW, Maskara N, et al. Logical quantum processor based on reconfigurable atom arrays. Nature. DOI: 10.1038/s41586-023-06927-3.
3. Monroe C, Risinger A, Katz O, Bondurant B, Biswas D. Implementing Real-Time Logical Qubit Error Detection & Correction on a Trapped Ion Quantum Computer. DOI: 10.26226/m.6275705766d5dcf63a311383.
4. Savin V, Vasić B, Raveendran N, Borah SK, Pacenti M. Quantum Low-Density Parity-Check Codes. arXiv. DOI: 10.48550/arxiv.2510.14090.
5. Devulapalli D, Gorshkov AV, Gottesman D, Gullans MJ, Schoute E. Toward a 2D Local Implementation of Quantum Low-Density Parity-Check Codes. PRX Quantum. DOI: 10.1103/prxquantum.6.010306.
6. Liyanage N, Wu Y, Zhong L, Houghton E. Network-Integrated Decoding System for Real-Time Quantum Error Correction with Lattice Surgery. DOI: 10.48550/arxiv.2504.11805.
7. Bigagli N, Shabani J, Namazi M, Cowan TE, Craddock AN. Towards entanglement swapping over 30 km in a three-node metropolitan quantum network in New York City. DOI: 10.1364/quantum.2025.qw4a.7.
8. Albertinale E, Cohen J, Lescanne R, Campagne-Ibarcq P, Sarlette A. Quantum control of a cat qubit with bit-flip times exceeding ten seconds. Nature. DOI: 10.1038/s41586-024-07294-3.
9. IBM Quantum Roadmap (Starling, 2029) and Quantinuum's accelerated roadmap to universal, fully fault-tolerant quantum computing — company technical blogs and press releases.
10. Cypris platform corpus analysis, quantum error correction / fault-tolerant quantum computing patent families. Indicative figures; 2025–2026 partial.

‍

Electrolysis has become the center of gravity in hydrogen innovation, and the electrolyzer patent landscape is where the clean-hydrogen transition is being contested. A joint study of global patent data by the European Patent Office and the International Energy Agency found that technologies motivated by climate concerns accounted for nearly 80 percent of all hydrogen-production patents by 2020, with growth driven chiefly by a sharp increase in innovation in water electrolysis, and that climate-driven hydrogen technologies generated roughly twice as many international patent families as established, fossil-based methods.¹ The commercial backdrop is a projected expansion of electrolyzer manufacturing on the order of a 65-fold increase in market size over the decade, as countries scale low-emissions hydrogen for hard-to-abate sectors.²,³ For R&D and IP teams, the strategic questions are which electrolyzer technology route to back and where defensible IP positions remain, and both are patent-landscape questions.

The landscape divides across four electrolyzer technologies at different maturity levels, each a distinct region of patenting, and each characterized in the US Department of Energy's comparative assessment of solid-oxide, alkaline, and proton-exchange-membrane electrolyzers.⁴ Alkaline electrolysis is the most mature and lowest-cost route, using a liquid alkaline electrolyte and avoiding scarce precious metals, so its patenting concentrates on efficiency, dynamic operation to follow variable renewable power, and stack scale-up. Proton-exchange-membrane (PEM) electrolysis offers compact, responsive operation well suited to variable renewables but relies on scarce platinum-group catalysts and specialized membranes, so a large share of its patenting targets catalyst loading reduction, membrane durability, and cost.⁵ Solid-oxide electrolysis (SOEC) operates at high temperature with high electrical efficiency and can co-electrolyze to produce syngas, but durability and thermal cycling are the central challenges, so patenting concentrates there. Anion-exchange-membrane (AEM) electrolysis is the newest route, aiming to combine PEM-like performance without precious-metal dependence, and it is the least mature and least crowded, which makes it a notable area of white space; its membranes and non-precious-metal catalysts are an active peer-reviewed research frontier.⁶

Geography and institutional origin further shape the landscape. The EPO and IEA analysis found Europe gaining an edge as a location for electrolyzer innovation and manufacturing investment, while Japan led patenting in hydrogen end-use for the automotive sector, and it noted that momentum in other end-use applications, such as aviation, shipping, and power generation, had not yet matched the attention those sectors receive.¹ The European Commission's Joint Research Centre has separately tracked the status of water electrolysis and hydrogen technology in the European Union, corroborating the region's manufacturing push.⁷ It also found that emerging low-emissions hydrogen carriers, including liquid organic hydrogen carriers and ammonia cracking, grew (by about 12.5 percent and 7.8 percent in international patent families respectively) with roughly half of that activity originating in universities and public research, an early-stage signal of where future commercial IP may form.¹ Because applications publish about eighteen months after filing, the most recent activity, particularly in the newer AEM and SOEC routes, is under-represented, so the current frontier is more active than granted-patent counts suggest.

The four electrolyzer routes and where white space sits

Alkaline. The most mature and lowest-cost route, avoiding precious metals; patenting concentrates on efficiency, dynamic operation, and scale-up, so it is comparatively crowded on core design.

PEM. Compact and responsive but reliant on platinum-group catalysts and specialized membranes; white space centers on catalyst reduction, membrane durability, and cost.

SOEC. High-temperature and high-efficiency with co-electrolysis potential, but durability and thermal cycling are the open problems where patenting and white space concentrate.

AEM. The newest route, aiming for PEM-like performance without precious metals; the least mature and least crowded, and therefore a notable area of white space.²

Carriers and end-use. Liquid organic hydrogen carriers and ammonia cracking are early-stage and university-driven, and several end-use sectors beyond automotive remain comparatively under-patented.¹

How AI-powered landscape and white space analysis helps

Resolving four technology routes at different maturities, across geographies and institutions, requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by route and by the problem being solved across varied terminology, attribution that normalizes filers to canonical entities and distinguishes university from commercial activity, and continuous monitoring that tracks the newer routes where recent activity is under-represented. Because electrolyzer advances appear in scientific literature before they are patented, reading both patents and literature gives the earliest signal of where the frontier and the white space are moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for multi-route energy fields such as hydrogen electrolysis across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by electrolyzer route, alkaline, PEM, SOEC, and AEM, and by the problem being solved, and normalizes filers to canonical entities, so a team can resolve which routes and problems are crowded and which, such as AEM and SOEC durability, remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying materials and engineering research, which is where electrolyzer advances appear first, and distinguishes university from commercial activity. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined route over time and flags new patents and papers as they publish, which is essential where the newest routes are under-represented by publication lag. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is electrolysis the focus of hydrogen patenting?

Electrolysis is the focus of hydrogen patenting because it can produce hydrogen with zero direct emissions when powered by renewable or nuclear electricity. A joint EPO and IEA study found that climate-motivated technologies accounted for nearly 80 percent of hydrogen-production patents by 2020, with growth driven chiefly by a surge in electrolysis. Climate-driven hydrogen technologies generated roughly twice the international patent families of established methods.

What are the main electrolyzer technologies?

The main electrolyzer technologies are alkaline, proton-exchange-membrane (PEM), solid-oxide (SOEC), and anion-exchange-membrane (AEM). They differ in maturity, cost, materials, and operating conditions, and each occupies a distinct region of the patent landscape. Alkaline is the most mature and AEM the newest.

Where is the white space in the electrolyzer patent landscape?

The white space in the electrolyzer patent landscape is concentrated in anion-exchange-membrane electrolysis, which is the newest and least crowded route, in solid-oxide durability and thermal cycling, in reducing precious-metal catalyst use and improving membrane durability in PEM, and in early-stage hydrogen carriers such as liquid organic carriers and ammonia cracking. Core alkaline design is comparatively crowded. The higher-value opportunities are in the newer routes and unsolved durability problems.

How do the electrolyzer routes trade off?

The electrolyzer routes trade off maturity, cost, and materials. Alkaline is mature and low-cost but less dynamic; PEM is responsive but relies on scarce platinum-group metals; SOEC is highly efficient but faces durability challenges; and AEM aims to combine PEM-like performance without precious metals but is the least mature. Each route's patenting concentrates on its specific weakness.

How fast is the electrolyzer market expected to grow?

The electrolyzer market is expected to grow rapidly, with the IEA projecting an expansion on the order of a 65-fold increase in market size over the decade as countries scale low-emissions hydrogen. This growth is the commercial driver behind the surge in electrolysis patenting. It also raises the value of securing defensible IP positions early.

Which regions lead electrolyzer innovation?

The EPO and IEA analysis found Europe gaining an edge as a location for electrolyzer innovation and manufacturing investment, while Japan led hydrogen end-use patenting in the automotive sector. Momentum in several other end-use sectors had not yet matched the attention they receive. The geographic distribution differs by technology route and end-use.

Why does electrolyzer analysis need scientific literature?

Electrolyzer analysis needs scientific literature because materials and engineering advances, particularly in catalysts, membranes, and the newer routes, appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view, and much early activity is university-driven. Cypris analyzes both across more than 500 million patents and scientific papers.

Which teams use electrolyzer patent landscape analysis?

Electrolyzer patent landscape analysis is used by R&D, innovation, IP, and strategy teams at electrolyzer and equipment makers, energy and industrial-gas companies, materials developers, and their partners, as well as investors. It informs which route to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across energy, advanced materials, chemicals, and other regulated industries.

How do you keep an electrolyzer landscape current?

Keeping an electrolyzer landscape current requires continuous monitoring, because the field moves quickly, the newer routes are advancing, and publication lag under-represents the most recent activity. A one-time landscape ages quickly. Cypris uses Agentic Monitoring to track a defined route and flag new patents and papers as they publish.

Endnotes

1. European Patent Office & International Energy Agency (2023). Hydrogen patents for a clean energy future: A global trend analysis of innovation along hydrogen value chains. https://www.iea.org/reports/hydrogen-patents-for-a-clean-energy-future
2. International Energy Agency, reported via World Economic Forum (2023). Hydrogen patent filings: Europe and Japan lead on innovation (projected ~65-fold electrolyzer market growth this decade). https://www.weforum.org/stories/2023/03/hydrogen-innovation-patents-technology/
3. International Energy Agency. Global Hydrogen Review (annual series). https://www.iea.org/reports/global-hydrogen-review-2024
4. Kelly, J. C., Elgowainy, A. & Iyer, R. (2022). Electrolyzers for Hydrogen Production: Solid Oxide, Alkaline, and Proton Exchange Membrane. US Department of Energy (OSTI). https://www.osti.gov/
5. US Department of Energy (2024). Hydrogen Shot: Water Electrolysis Technology Assessment. https://www.energy.gov/
6. Zhang, M. et al. (2024). Advanced development of anion-exchange membrane electrolyzers for hydrogen production: from anion-exchange membranes to membrane electrode assemblies. Chemical Communications. https://doi.org/10.1039/D3CC05904A
7. European Commission Joint Research Centre (2023). Water electrolysis and hydrogen in the European Union: Status Report on Technology Development, Trends, Value Chains and Markets. https://publications.jrc.ec.europa.eu/

‍